Xu N - Search Results

1

Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach.

Jiang J, Ding Y, Lu J, Chen Y, Chen Y, Zhao W, Chen W, Kong M, Li C, Teng X, Zhou Q, Xu N, Zhou D, Zhou Z, Wang H, Teng L. Jiang J, et al. Among authors: xu n. Int J Biol Sci. 2022 Aug 29;18(14):5554-5574. doi: 10.7150/ijbs.71449. eCollection 2022. Int J Biol Sci. 2022. PMID: 36147475 Free PMC article.

2

Prognostic value of perineural invasion in gastric cancer: a systematic review and meta-analysis.

Deng J, You Q, Gao Y, Yu Q, Zhao P, Zheng Y, Fang W, Xu N, Teng L. Deng J, et al. Among authors: xu n. PLoS One. 2014 Feb 21;9(2):e88907. doi: 10.1371/journal.pone.0088907. eCollection 2014. PLoS One. 2014. PMID: 24586437 Free PMC article. Review.

3

A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.

Jiang H, Qian J, Zhao P, Zhang X, Zheng Y, Mao C, Zheng Y, Chen L, Wang Y, Mou H, Fang W, Teng L, Xu N. Jiang H, et al. Among authors: xu n. Cancer Chemother Pharmacol. 2015 Jul;76(1):197-203. doi: 10.1007/s00280-015-2782-z. Epub 2015 May 27. Cancer Chemother Pharmacol. 2015. PMID: 26013324 Clinical Trial.

4

90-gene signature assay for tissue origin diagnosis of brain metastases.

Zheng Y, Ding Y, Wang Q, Sun Y, Teng X, Gao Q, Zhong W, Lou X, Xiao C, Chen C, Xu Q, Xu N. Zheng Y, et al. Among authors: xu n, xu q. J Transl Med. 2019 Oct 1;17(1):331. doi: 10.1186/s12967-019-2082-1. J Transl Med. 2019. PMID: 31570099 Free PMC article.

5

Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer.

Wu M, Ding Y, Jiang X, Chen Y, Wu N, Li L, Wang H, Huang Y, Xu N, Teng L. Wu M, et al. Among authors: xu n. Front Oncol. 2020 Jan 17;9:1544. doi: 10.3389/fonc.2019.01544. eCollection 2019. Front Oncol. 2020. PMID: 32010630 Free PMC article.

6

Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer.

Ding Y, Chen Y, Wu M, Li L, Huang Y, Wang H, Wang H, Yu X, Xu N, Teng L. Ding Y, et al. Among authors: xu n. Oncol Lett. 2020 Jul;20(1):215-225. doi: 10.3892/ol.2020.11543. Epub 2020 Apr 15. Oncol Lett. 2020. PMID: 32537023 Free PMC article.

7

Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer.

Wang H, Ding Y, Li N, Wu L, Gao Y, Xiao C, Jiang H, Zheng Y, Mao C, Deng J, Wang H, Xu N. Wang H, et al. Among authors: xu n. Front Oncol. 2020 Jun 19;10:841. doi: 10.3389/fonc.2020.00841. eCollection 2020. Front Oncol. 2020. PMID: 32637353 Free PMC article.

8

Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers.

Chen Y, Zhou Q, Wang H, Zhuo W, Ding Y, Lu J, Wu G, Xu N, Teng L. Chen Y, et al. Among authors: xu n. Cancers (Basel). 2020 Aug 10;12(8):2236. doi: 10.3390/cancers12082236. Cancers (Basel). 2020. PMID: 32785164 Free PMC article. Review.

9

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial.

Jiang H, Zheng Y, Qian J, Mao C, Xu X, Li N, Xiao C, Wang H, Teng L, Zhou H, Wang S, Zhu D, Peng B, Shen L, Xu N. Jiang H, et al. Among authors: xu n, xu x. BMC Cancer. 2020 Aug 14;20(1):760. doi: 10.1186/s12885-020-07251-z. BMC Cancer. 2020. PMID: 32795349 Free PMC article. Clinical Trial.

10

Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study.

Jiang H, Zheng Y, Qian J, Mao C, Xu X, Li N, Xiao C, Wang H, Teng L, Zhou H, Wang S, Zhu D, Sun T, Yu Y, Guo W, Xu N. Jiang H, et al. Among authors: xu n, xu x. Cancer Immunol Immunother. 2021 Mar;70(3):857-868. doi: 10.1007/s00262-020-02738-x. Epub 2020 Oct 17. Cancer Immunol Immunother. 2021. PMID: 33070260 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,016 results

Search Page

Filters